Ash Stevens to make API for Takeda's new oral blood cancer drug
The US FDA has cleared Ash Stevens to make the API for Takeda's new multiple myeloma drug Ninlaro, which is the first oral proteasome inhibitor to be approved in the country.
Archives for November 24, 2015
Megamerger Pfall-out? $160bn Pfizer-Allergan deal to hit CROs in short-term, analysts
The $160bn Pfizer-Allergan megamerger could lead to booking cancellations in the short-term say analysts, but CROs – especially Icon, Parexel and PPD - should ultimately benefit.
CRL buys German mouse model CRO for €34m
Charles River has acquired German preclinical CRO Oncotest GmbH in a €34m ($36m) cash deal.
AZ not worried about giving Sanofi a potential blockbuster in swap deal
AstraZeneca says it had no worries about giving rival Sanofi a potential blockbuster drug when the two exchanged compound library molecules this month.
EC mulls changes to Orphan Drug rules
Tweaks to EU orphan drug rules (OD) may be needed to accommodate Ebola treatment development and block industry attempts to delay generic entry says the European Commission.